Institutional Ownership Prime Medicine, Inc. (PRME)
This table provides information about the institutional ownership of Prime Medicine, Inc. (PRME). We have compiled data on the 136 institutions that hold shares in the stock, with a total of 60.9 Million shares, which have been reported (via 13F filing form) to have a value of $182 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Alphabet Inc.
Mountain View, CA |
Feb 06, 2025 Q4 2024 |
15,062,498
shares
|
$44.7 Million
3.11% of portfolio
|
Q1 2024
Added 26.98%
|
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
Feb 04, 2025 Q4 2024 |
5,150,233
shares
|
$15.3 Million
0.13% of portfolio
|
Q4 2024
Reduced 9.02%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
5,110,418
shares
|
$15.2 Million
0.0% of portfolio
|
Q2 2024
Added 36.05%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
3,977,828
shares
|
$11.8 Million
0.01% of portfolio
|
Q4 2024
Added 4.48%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,655,317
shares
|
$10.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 25.25%
|
|
Nikko Asset Management Americas, Inc.
|
Feb 10, 2025 Q4 2024 |
3,090,180
shares
|
$9.18 Million
0.1% of portfolio
|
Q4 2024
Reduced 2.9%
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Jan 28, 2025 Q4 2024 |
3,090,180
shares
|
$9.18 Million
0.01% of portfolio
|
Q4 2024
Reduced 3.14%
|
|
Redmile Group, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
2,074,350
shares
|
$6.16 Million
0.47% of portfolio
|
Q1 2024
Added 56.63%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
1,874,571
shares
|
$5.57 Million
0.0% of portfolio
|
Q4 2024
Reduced 14.72%
|
|
Mwg Management Ltd.
Washington, DC |
Feb 14, 2025 Q4 2024 |
1,792,210
shares
|
$5.32 Million
7.04% of portfolio
|
Q2 2023
Reduced 2.38%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,584,476
shares
|
$4.71 Million
0.0% of portfolio
|
Q4 2024
Added 2.49%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,467,606
shares
|
$4.36 Million
0.0% of portfolio
|
Q4 2024
Added 7.91%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,154,181
shares
|
$3.43 Million
0.0% of portfolio
|
Q4 2024
Added 0.63%
|
|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,028,466
shares
|
$3.05 Million
0.03% of portfolio
|
Q4 2022
New holding
|
|
Westwood Holdings Group Inc
Dallas, TX |
Feb 14, 2025 Q4 2024 |
883,129
shares
|
$2.62 Million
0.02% of portfolio
|
Q4 2024
Added 96.48%
|
|
Greenwich Wealth Management LLC
Greenwich, CT |
Feb 10, 2025 Q4 2024 |
774,001
shares
|
$2.3 Million
0.16% of portfolio
|
Q4 2024
Added 5.59%
|
|
Farallon Capital Management LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
750,000
shares
|
$2.23 Million
0.01% of portfolio
|
Q1 2024
New holding
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
700,000
shares
|
$2.08 Million
0.1% of portfolio
|
Q1 2024
New holding
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
544,937
shares
|
$1.62 Million
0.0% of portfolio
|
Q4 2024
Added 3.89%
|
|
Moore Capital Management, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
500,000
shares
|
$1.49 Million
0.02% of portfolio
|
Q1 2024
New holding
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
484,591
shares
|
$1.44 Million
0.0% of portfolio
|
Q4 2024
Added 4.44%
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
430,613
shares
|
$1.28 Million
0.0% of portfolio
|
Q4 2024
Reduced 11.24%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
421,898
shares
|
$1.25 Million
0.0% of portfolio
|
Q4 2024
Added 91.65%
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
405,228
shares
|
$1.2 Million
0.36% of portfolio
|
Q4 2024
Reduced 25.0%
|
|
Walleye Capital LLC
Plymouth, MN |
Feb 13, 2025 Q4 2024 |
403,739
shares
|
$1.2 Million
0.0% of portfolio
|
Q4 2024
Added 272.54%
|